Elazer Reuven Edelman

Brookline, MA, United States of America

Elazer Reuven Edelman

USPTO Granted Patents = 56 

 

 

Average Co-Inventor Count = 3.4

ph-index = 20

Forward Citations = 1,248(Granted Patents)

Forward Citations (Not Self Cited) = 1,214(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Brookline, MA (US) (1992 - 2024)
  • Cambridge, MA (US) (2021 - 2024)

Company Filing History:


Years Active: 1992-2025

Loading Chart...
Loading Chart...
Loading Chart...
56 patents (USPTO):Explore Patents

Title: The Innovative Journey of Elazer Reuven Edelman

Introduction: Elazer Reuven Edelman is a distinguished inventor hailing from Brookline, Massachusetts. His groundbreaking work in the field of medical technology has revolutionized the way we approach healthcare.

Latest Patents: Edelman holds several patents in the medical device industry, focusing on advancements in drug-eluting stents and biomaterials for tissue engineering.

Career Highlights: With a career spanning over decades, Edelman has made significant contributions to the medical field through his innovative research and inventions. He is renowned for his expertise in biomedical engineering and has been a driving force behind numerous life-saving technologies.

Collaborations: Throughout his career, Edelman has collaborated with leading researchers, medical professionals, and industry experts to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge medical devices that have improved patient outcomes worldwide.

Conclusion: Elazer Reuven Edelman's dedication to innovation and his passion for improving healthcare have solidified his place as a pioneering inventor in the field of medical technology. His work continues to inspire future generations of inventors and researchers in their quest to make the world a healthier place.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…